Skip to main content
logo
Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
27.32
-1.13 (-3.97%)
At close: Sep 12, 2025, 4:00 PM EDT
27.52
+0.20 (0.73%)
After-hours: Sep 12, 2025, 4:00 PM EDT

Inhibrx Biosciences Revenue

Inhibrx Biosciences had revenue of $1.30M in the quarter ending June 30, 2025, with 1,200.00% growth. This brings the company's revenue in the last twelve months to $1.40M, down -24.45% year-over-year. In the year 2024, Inhibrx Biosciences had annual revenue of $200.00K, down -88.89%.

Revenue (ttm)
$1.40M
Revenue Growth
-24.45%
P/S Ratio
284.74
Revenue / Employee
$8,696
Employees
161
Market Cap
398.64M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024200.00K-1.60M-88.89%
Dec 31, 20231.80M485.00K36.88%
Dec 31, 20221.32M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

INBX News

More News